CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Maintaining a consistent, high-density E. coli culture under consistent growth conditions allows the system to perform ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

The new tests for autism are not yet reliable enough to be offered commercially. None of the tests has gone through large ...

Revenue -- $14.5 million in the fiscal fourth quarter ended Sept. 30, 2025, up 11% year-over-year. Gross margin -- 37% in the ...

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...

Researchers in Japan built a miniature human brain circuit using fused stem-cell–derived organoids, allowing them to watch ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

"Cellenkos gains FDA orphan drug status for CK0804 to treat myelofibrosis" was originally created and published by ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most known CRISPR systems target invading pathogens' DNA and chop it up to ...

This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).

Proven Performance Caterpillar has been at the forefront of automation for more than 30 years. The company’s entry into ...